23-044-008
Quidel™ Lyra Adenovirus Molecular Assay
Manufacturer: Quidel™
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Pack of 96 | 23-044-008-Pack-of-96 | In Stock | ₹ 3,57,157.00 |
23-044-008 - Pack of 96
In Stock
Quantity
1
Base Price: ₹ 3,57,157.00
GST (18%): ₹ 64,288.26
Total Price: ₹ 4,21,445.26
Certifications/Compliance
FDA approved*
Control Sets
Included
CE Marker
Yes
Detectable Analytes
Human adenovirus (HAdV) viral DNA
Sample Type
Nasal or Nasopharyngeal Swab
Type
Molecular Testing
For Use With (Equipment)
FDA approved for use on Applied Biosystems™ 7500 Fast Dx Real-Time PCR Instrument
Packaging Type
Kit
Specificity
0.955
Form
Liquid
Content And Storage
2°C to 8°C
Description
Qualitative detection of human adenovirus (HAdV) viral DNA isolated from nasal and nasopharyngeal swab specimens obtained from individuals exhibiting signs and symptoms of acute respiratory infections
Clia Complexity
High
DoA Calibrators
No
Sensitivity
1
For Use With (Application)
RT-PCR
Includes
Tests and controls
Quantity
96 Tests/Kit
Test Time
<75 min. after extraction
Related Products
Description
- RT-PCR One-step reagent setup Results in <75 minutes after extraction No freezer necessary Refrigration storage Long shelf-life Flexible testing format Includes 12 x 8 master mix, rehydration solution and liquid process controls Ability to customize panel of results
SAFETY INFORMATION
- ShelfLife : 2 Years from DOM
Compare Similar Items
Show Difference
Certifications/Compliance: FDA approved*
Control Sets: Included
CE Marker: Yes
Detectable Analytes: Human adenovirus (HAdV) viral DNA
Sample Type: Nasal or Nasopharyngeal Swab
Type: Molecular Testing
For Use With (Equipment): FDA approved for use on Applied Biosystems™ 7500 Fast Dx Real-Time PCR Instrument
Packaging Type: Kit
Specificity: 0.955
Form: Liquid
Content And Storage: 2°C to 8°C
Description: Qualitative detection of human adenovirus (HAdV) viral DNA isolated from nasal and nasopharyngeal swab specimens obtained from individuals exhibiting signs and symptoms of acute respiratory infections
Clia Complexity: High
DoA Calibrators: No
Sensitivity: 1
For Use With (Application): RT-PCR
Includes: Tests and controls
Quantity: 96 Tests/Kit
Test Time: <75 min. after extraction
Certifications/Compliance:
FDA approved*
Control Sets:
Included
CE Marker:
Yes
Detectable Analytes:
Human adenovirus (HAdV) viral DNA
Sample Type:
Nasal or Nasopharyngeal Swab
Type:
Molecular Testing
For Use With (Equipment):
FDA approved for use on Applied Biosystems™ 7500 Fast Dx Real-Time PCR Instrument
Packaging Type:
Kit
Specificity:
0.955
Form:
Liquid
Content And Storage:
2°C to 8°C
Description:
Qualitative detection of human adenovirus (HAdV) viral DNA isolated from nasal and nasopharyngeal swab specimens obtained from individuals exhibiting signs and symptoms of acute respiratory infections
Clia Complexity:
High
DoA Calibrators:
No
Sensitivity:
1
For Use With (Application):
RT-PCR
Includes:
Tests and controls
Quantity:
96 Tests/Kit
Test Time:
<75 min. after extraction
Certifications/Compliance: __
Control Sets: __
CE Marker: __
Detectable Analytes: __
Sample Type: __
Type: __
For Use With (Equipment): __
Packaging Type: __
Specificity: __
Form: __
Content And Storage: __
Description: __
Clia Complexity: __
DoA Calibrators: __
Sensitivity: __
For Use With (Application): __
Includes: __
Quantity: __
Test Time: __
Certifications/Compliance:
__
Control Sets:
__
CE Marker:
__
Detectable Analytes:
__
Sample Type:
__
Type:
__
For Use With (Equipment):
__
Packaging Type:
__
Specificity:
__
Form:
__
Content And Storage:
__
Description:
__
Clia Complexity:
__
DoA Calibrators:
__
Sensitivity:
__
For Use With (Application):
__
Includes:
__
Quantity:
__
Test Time:
__
Certifications/Compliance: Emergency Use Authorization (EUA)
Control Sets: Included
CE Marker: Yes
Detectable Analytes: SARS-CoV-2
Sample Type: Nasal, Nasopharyngeal, Oropharyngeal Swab
Type: Molecular Testing
For Use With (Equipment): Emergency Use Authorization (EUA) for use on bioMerieux NucliSENS™ easyMAG™ system or EMAG system, followed by RT-PCR on one of six thermocyclers: Applied Biosystems™ 7500 Fast Dx, Applied Biosystems 7500 Standard, QuantStudioTM Real-Time PCR Instrument, Roche LightCycler™ 480, BioRad CFX96 Touch, or Qiagen Rotor-Gene Q
Packaging Type: Kit
Specificity: NPA – 92/92 = 100% (95% CI: 95.99 to 100%)
Form: Liquid
Content And Storage: 2°C to 8°C
Description: __
Clia Complexity: High
DoA Calibrators: No
Sensitivity: PPA – 92/92 = 100% (95% CI: 95.99 to 100%)
For Use With (Application): RT-PCR
Includes: Tests and controls
Quantity: 96 Tests/Kit
Test Time: <75 min. after extraction
Certifications/Compliance:
Emergency Use Authorization (EUA)
Control Sets:
Included
CE Marker:
Yes
Detectable Analytes:
SARS-CoV-2
Sample Type:
Nasal, Nasopharyngeal, Oropharyngeal Swab
Type:
Molecular Testing
For Use With (Equipment):
Emergency Use Authorization (EUA) for use on bioMerieux NucliSENS™ easyMAG™ system or EMAG system, followed by RT-PCR on one of six thermocyclers: Applied Biosystems™ 7500 Fast Dx, Applied Biosystems 7500 Standard, QuantStudioTM Real-Time PCR Instrument, Roche LightCycler™ 480, BioRad CFX96 Touch, or Qiagen Rotor-Gene Q
Packaging Type:
Kit
Specificity:
NPA – 92/92 = 100% (95% CI: 95.99 to 100%)
Form:
Liquid
Content And Storage:
2°C to 8°C
Description:
__
Clia Complexity:
High
DoA Calibrators:
No
Sensitivity:
PPA – 92/92 = 100% (95% CI: 95.99 to 100%)
For Use With (Application):
RT-PCR
Includes:
Tests and controls
Quantity:
96 Tests/Kit
Test Time:
<75 min. after extraction
Certifications/Compliance: Emergency Use Authorization (EUA)
Control Sets: Included
CE Marker: Yes
Detectable Analytes: SARS-CoV-2
Sample Type: __
Type: Molecular Testing
For Use With (Equipment): Emergency Use Authorization (EUA) for use on bioMerieux NucliSENS™ easyMAG™ system or EMAG system, followed by RT-PCR on one of six thermocyclers: Applied Biosystems™ 7500 Fast Dx, Applied Biosystems 7500 Standard, QuantStudioTM Real-Time PCR Instrument, Roche LightCycler™ 480, BioRad CFX96 Touch, or Qiagen Rotor-Gene Q
Packaging Type: Kit
Specificity: NPA – 92/92 = 100% (95% CI: 95.99 to 100%)
Form: __
Content And Storage: 2°C to 8°C
Description: __
Clia Complexity: High
DoA Calibrators: No
Sensitivity: PPA – 92/92 = 100% (95% CI: 95.99 to 100%)
For Use With (Application): RT-PCR
Includes: Tests and controls
Quantity: 96 Tests/Kit
Test Time: <75 min. after extraction
Certifications/Compliance:
Emergency Use Authorization (EUA)
Control Sets:
Included
CE Marker:
Yes
Detectable Analytes:
SARS-CoV-2
Sample Type:
__
Type:
Molecular Testing
For Use With (Equipment):
Emergency Use Authorization (EUA) for use on bioMerieux NucliSENS™ easyMAG™ system or EMAG system, followed by RT-PCR on one of six thermocyclers: Applied Biosystems™ 7500 Fast Dx, Applied Biosystems 7500 Standard, QuantStudioTM Real-Time PCR Instrument, Roche LightCycler™ 480, BioRad CFX96 Touch, or Qiagen Rotor-Gene Q
Packaging Type:
Kit
Specificity:
NPA – 92/92 = 100% (95% CI: 95.99 to 100%)
Form:
__
Content And Storage:
2°C to 8°C
Description:
__
Clia Complexity:
High
DoA Calibrators:
No
Sensitivity:
PPA – 92/92 = 100% (95% CI: 95.99 to 100%)
For Use With (Application):
RT-PCR
Includes:
Tests and controls
Quantity:
96 Tests/Kit
Test Time:
<75 min. after extraction